DERIVES DE QUINOXALINE UTILISES EN TANT QU'ANTAGONISTES DU RECEPTEUR DE L'ADENOSINE
- 专利权人:
- MERCK PATENT GMBH
- 发明人:
- TANZER, EVA-MARIA,SCHIEMANN, KAI,KLEIN, MARKUS
- 申请号：
- CA3073343
- 公开号：
- CA3073343A1
- 申请日:
- 2018.08.20
- 申请国别(地区):
- CA
- 年份:
- 2019
- 代理人:
- 摘要：
- The invention relates to quinoxaline derivatives of the general formula (I) and the use of the compounds of the present invention for the treatment and/or prevention of hyperproliferative or infectious disease sand disorders in mammals, especially humans, and pharmaceutical compositions containing such compound.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Preparations used to promote proliferation of neural stem cells, preparations used for prevention or treatment of diseases related to decrease in neural stem cells, preparations used to promote post-synaptic formation, prevention of diseases related to reduction of post-synaptic formation or Formulation used for treatment and screening method
- USE OF MITOCHONDRIALLY-ADDRESSED COMPOUNDS FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES
- APPLICATION OF TRIACETHYL-3-HYDROXYPHENYLENADENOSINE FOR THE PRODUCTION OF A PHARMACEUTICAL MEDICINE FOR THE PREVENTION OR TREATMENT OF A NON-ALCOHOLIC LIVER LIVER DISEASE DISEASE
- PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND PREVENTION OF ORTHOPOXVIRUS INFECTIONS AND ASSOCIATED DISEASES
- 5 - fluoro substituted 1h pirazolopiridinas and its use
